Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1-Year Interim Results from Study SRP-9001-103 (ENDEAVOR) [Annals of Neurology August 2023]
Posted byReality Price
This is a widget ready area. Add some and they will appear here.
